These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 23782265

  • 21. The roles of SOCS3 and STAT3 in bacterial infection and inflammatory diseases.
    Gao Y, Zhao H, Wang P, Wang J, Zou L.
    Scand J Immunol; 2018 Dec; 88(6):e12727. PubMed ID: 30341772
    [Abstract] [Full Text] [Related]

  • 22. Signal transducer and activator of transcription 3 (STAT3) and Suppressor of Cytokine Signaling (SOCS3) balance controls cytotoxicity and IL-10 expression in decidual-like natural killer cell line NK-92.
    Braunschweig A, Poehlmann TG, Busch S, Schleussner E, Markert UR.
    Am J Reprod Immunol; 2011 Oct; 66(4):329-35. PubMed ID: 21385272
    [Abstract] [Full Text] [Related]

  • 23. Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.
    Serrano-Marco L, Rodríguez-Calvo R, El Kochairi I, Palomer X, Michalik L, Wahli W, Vázquez-Carrera M.
    Diabetes; 2011 Jul; 60(7):1990-9. PubMed ID: 21617181
    [Abstract] [Full Text] [Related]

  • 24. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
    Oguro T, Ishibashi K, Sugino T, Hashimoto K, Tomita S, Takahashi N, Yanagida T, Haga N, Aikawa K, Suzutani T, Yamaguchi O, Kojima Y.
    Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
    [Abstract] [Full Text] [Related]

  • 25. SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.
    Luckett-Chastain LR, Ihnat MA, Mickle-Kawar BM, Gallucci RM.
    J Interferon Cytokine Res; 2012 May; 32(5):207-15. PubMed ID: 22313262
    [Abstract] [Full Text] [Related]

  • 26. Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjögren's syndrome.
    Vartoukian SR, Tilakaratne WM, Seoudi N, Bombardieri M, Bergmeier L, Tappuni AR, Fortune F.
    Clin Exp Immunol; 2014 Sep; 177(3):618-29. PubMed ID: 24827536
    [Abstract] [Full Text] [Related]

  • 27. A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals.
    da Silva CG, Studer P, Skroch M, Mahiou J, Minussi DC, Peterson CR, Wilson SW, Patel VI, Ma A, Csizmadia E, Ferran C.
    Hepatology; 2013 May; 57(5):2014-25. PubMed ID: 23238769
    [Abstract] [Full Text] [Related]

  • 28. Ohwia caudata extract relieves the IL-17A-induced inflammatory response of synoviocytes through modulation of SOCS3 and JAK2/STAT3 activation.
    Lu CY, Kuo CH, Kuo WW, Hsieh DJ, Wang TF, Shih CY, Lin PY, Lin SZ, Ho TJ, Huang CY.
    Environ Toxicol; 2023 Aug; 38(8):1914-1924. PubMed ID: 37163279
    [Abstract] [Full Text] [Related]

  • 29. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
    Lee TL, Yeh J, Van Waes C, Chen Z.
    Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
    [Abstract] [Full Text] [Related]

  • 30. The hepatitis C virus (HCV) protein, p7, suppresses inflammatory responses to tumor necrosis factor (TNF)-α via signal transducer and activator of transcription (STAT)3 and extracellular signal-regulated kinase (ERK)-mediated induction of suppressor of cytokine signaling (SOCS)3.
    Convery O, Gargan S, Kickham M, Schroder M, O'Farrelly C, Stevenson NJ.
    FASEB J; 2019 Aug; 33(8):8732-8744. PubMed ID: 31163989
    [Abstract] [Full Text] [Related]

  • 31. Suppressor of cytokine signaling-3 suppresses the ability of activated signal transducer and activator of transcription-3 to stimulate neurite growth in rat primary sensory neurons.
    Miao T, Wu D, Zhang Y, Bo X, Subang MC, Wang P, Richardson PM.
    J Neurosci; 2006 Sep 13; 26(37):9512-9. PubMed ID: 16971535
    [Abstract] [Full Text] [Related]

  • 32. Expression of suppressor of cytokine signalling 3 (SOCS3) in human bladder epithelial cells infected with uropathogenic Escherichia coli.
    Demirel I, Säve S, Kruse R, Persson K.
    APMIS; 2013 Feb 13; 121(2):158-67. PubMed ID: 23030674
    [Abstract] [Full Text] [Related]

  • 33. Glucocorticoids increase interleukin-6-dependent gene induction by interfering with the expression of the suppressor of cytokine signaling 3 feedback inhibitor.
    Dittrich A, Khouri C, Sackett SD, Ehlting C, Böhmer O, Albrecht U, Bode JG, Trautwein C, Schaper F.
    Hepatology; 2012 Jan 13; 55(1):256-66. PubMed ID: 21898505
    [Abstract] [Full Text] [Related]

  • 34. Suppressor of cytokine signaling 3 inhibits breast tumor kinase activation of STAT3.
    Gao Y, Cimica V, Reich NC.
    J Biol Chem; 2012 Jun 15; 287(25):20904-12. PubMed ID: 22547065
    [Abstract] [Full Text] [Related]

  • 35. IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain.
    Zhang L, Badgwell DB, Bevers JJ, Schlessinger K, Murray PJ, Levy DE, Watowich SS.
    Mol Cell Biochem; 2006 Aug 15; 288(1-2):179-89. PubMed ID: 16718380
    [Abstract] [Full Text] [Related]

  • 36. CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3.
    Tang Q, Jiang J, Liu J.
    Inflammation; 2015 Dec 15; 38(6):2049-56. PubMed ID: 26047948
    [Abstract] [Full Text] [Related]

  • 37. Interferon alpha antagonizes STAT3 and SOCS3 signaling triggered by hepatitis C virus.
    Zhao LJ, He SF, Wang W, Ren H, Qi ZT.
    Cytokine; 2016 Apr 15; 80():48-55. PubMed ID: 26945996
    [Abstract] [Full Text] [Related]

  • 38. Interleukin-6 trans-signalling induces vascular endothelial growth factor synthesis partly via Janus kinases-STAT3 pathway in human mesothelial cells.
    Yang X, Lin A, Jiang N, Yan H, Ni Z, Qian J, Fang W.
    Nephrology (Carlton); 2017 Feb 15; 22(2):150-158. PubMed ID: 26869278
    [Abstract] [Full Text] [Related]

  • 39. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo.
    Pietrangelo A, Dierssen U, Valli L, Garuti C, Rump A, Corradini E, Ernst M, Klein C, Trautwein C.
    Gastroenterology; 2007 Jan 15; 132(1):294-300. PubMed ID: 17241879
    [Abstract] [Full Text] [Related]

  • 40. SHPS-1/SIRP1alpha contributes to interleukin-6 signalling.
    Sobota RM, Müller PJ, Khouri C, Ullrich A, Poli V, Noguchi T, Heinrich PC, Schaper F.
    Cell Signal; 2008 Jul 15; 20(7):1385-91. PubMed ID: 18450421
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.